Skip to content

Addiction: all studies

Page 288 of 857: studies 2,871 to 2,880 of 8,563, newest first. Back to the addiction overview

Research

Behavioral and genetic analysis of the effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) in C. elegans.

bioRxiv : the preprint server for biology May 23, 2025 Amanda M. White, Adele D. Bauer, Serge Faumont et al. preprint

Psychedelics show promise in treating depression, PTSD, and substance use disorder, prompting research into their mechanisms of action. Most studies use rodent models, but genetic tools can be challenging to apply. Invertebrate models, like C. elegans , offer a cost-effective alternative with short generation times and genetic tractability. This study examined the worm's response to the...

DOI: 10.1101/2025.03.03.641301 (opens in new tab) Full text (opens in new tab) Psychedelics Animal-behavior Drug-research Molecular-biology

Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists.

British Journal of Pharmacology May 23, 2025 Trevor Sharp, Aurelija Ippolito 8 citations

Psychedelic drugs such as LSD and psilocin were once relegated to the fringes of medical research because of their association with counterculture movements and a perceived concern about harm through recreational use, and their consequent legal prohibition in the early 1970s. However, these drugs are now experiencing a renaissance in the field of psychiatry based on increasing evidence that...

[Psilocybin in the setting of treatment-resistant unipolar depression: A case report].

L'Encephale May 23, 2025 Maroussia Dumenil, Gabriel Cordova, Wissam El-Hage 1 citation

Current antidepressants have shown certain limitations in the treatment of unipolar depression. Their long onset of action, interactions, and side effects are obstacles to achieving lasting remission of this prevalent, often chronic or recurrent, pathology. Faced with this clinical necessity, research efforts have intensified in recent years around psychedelic drugs, with a particular focus on...

Cultivating Adolescents’ Self-Compassion Through Mindfulness: The Role of Self-Regulation at Both the Individual- and Classroom-Level

Contemporary School Psychology May 21, 2025 Rachel A. Razza, Qingyang Liu, Ruohan Feng et al. 1 citation

Abstract School-based mindfulness programs help students manage stress and promote well-being. These programs largely reflect a developmental psychological mindfulness framework that posits that intrinsic states of mindfulness and basic compassion can be cultivated into traits through socialization and training. Yet less is known about how program effects vary depending on individual and...

Altered states of consciousness induced by online chanting meditation

Current Psychology May 21, 2025 Gemma Perry, Yanan Sun, Vince Polito et al.

Chanting is a universal practice with deep ethnocultural roots. More recently, chanting has become popular on online platforms and meditation apps which have extended chanting practices beyond their original cultural, sacred, and healing traditions. The aim of the current study was to determine if online chanting meditation promotes altered states of consciousness and psychosocial benefits when...

Inhibition Mechanism of Ketamine-Apatinib by CYP2C9 and 3A4: A Prediction of Possible Drug-Drug Interaction.

Biopharmaceutics & drug disposition May 21, 2025 Xiang Zheng, Haiyan Chen, Dan Lin et al. 2 citations

Most cancer patients experience severe pain, and apatinib, a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, demonstrates therapeutic efficacy against gastric cancer. Ketamine, a psychotropic drug used for cancer pain relief, exhibits potential in inhibiting gastric cancer progression but is associated with dose-dependent adverse effects including neurological toxicity and...

DOI: 10.1002/bdd.70008 (opens in new tab) Full text (opens in new tab) Ketamine Apatinib Competitive inhibition Cytochrome p450 proteins +5

Bioactive ketamine metabolite exerts in vivo neuroplastogenic effects to improve hippocampal function in a treatment-resistant depression model.

Cell Reports May 21, 2025 Lace M Riggs, Sage Aronson, Ta-Chung M. Mou et al. 2 citations

An acute increase in excitatory synaptic transmission contributes to the rapid antidepressant actions of neuroplastogens, including ketamine and its bioactive metabolite, (2R,6R)-hydroxynorketamine (HNK). It is hypothesized that drug-induced metaplastic changes in synaptic strength account for therapeutically relevant behavioral adaptations in vivo. Using the plasticity-deficient Wistar Kyoto...

Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa

Physiology & Behavior May 20, 2025 Kaspar McCoy, Felicia Reed, Kyna‐anne Conn et al. 4 citations

Psilocybin, a serotonergic psychedelic, has emerged as a promising treatment for a range of mental health conditions, including anorexia nervosa. Recent insights from animal models and human imaging studies suggest psilocybin enhances cognitive flexibility and modifies reward processing - two core processes disrupted in anorexia nervosa. Both cognitive flexibility and reward processing are...

Half a Century of Research for Mind–Body Interventions: A Scientometric Analysis

Mindfulness May 17, 2025 Michel Sabé, Chaomei Chen, Davy Vancampfort et al. 7 citations

Abstract Objectives We conducted a scientometric analysis on mind–body interventions to assess themes and trends in recent decades, providing insights for prospective research directions. Our systematic search, completed on 1 November, 2023, encompassed the Web of Science Core Collection and focused on scientific publications related to contemplative practices: Mindfulness, Yoga, Qi-gong,...

DOI: 10.1007/s12671-025-02592-x (opens in new tab) Full text (opens in new tab) Mindfulness Psychological intervention Public health Psychotherapist +2